| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/04/1997 | US5608039 Single chain B3 antibody fusion proteins and their uses |
| 03/04/1997 | US5608037 Genetic engineering and proteins |
| 03/04/1997 | US5608035 Peptides and compounds that bind to the IL-1 receptor |
| 03/04/1997 | US5607974 Treatment of diseases associated with cysteine deficiency |
| 03/04/1997 | US5607967 Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid |
| 03/04/1997 | US5607924 DNA photocleavage using texaphyrins |
| 03/04/1997 | US5607921 Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof |
| 03/04/1997 | US5607920 Pharmaceutical and diagnostic aid with cmp; isolation of cmp by isolating chondrocytes, separating membrane proteins therefrom, isolating concanavalin a-binding glycoproteins with concanavalin a-affinity column, isolating cmp |
| 03/04/1997 | US5607918 Vascular endothelial growth factor-B and DNA coding therefor |
| 03/04/1997 | US5607917 Methods for reducing blood loss |
| 03/04/1997 | US5607916 Method and composition for the treatment of septic shock |
| 03/04/1997 | US5607915 Pulmonary delivery of active fragments of parathyroid hormone |
| 03/04/1997 | US5607914 Polypeptides for fungicides on plants |
| 03/04/1997 | US5607862 Assay for N-terminal type I collagen telopeptide that survives bone resorption in vivo |
| 03/04/1997 | US5607858 Pentapeptides or hexapeptide amides for diagnosis and anticoagulants |
| 03/04/1997 | US5607847 Cells, monoclonal antibodies and hybridomas |
| 03/04/1997 | US5607846 Vaccine for moraxella catarrhalis |
| 03/04/1997 | US5607844 Mammalian augmenter of liver regeneration and variants thereof |
| 03/04/1997 | US5607843 Dna for gene expression and proteins in cells |
| 03/04/1997 | US5607840 Protein hydrolysate derived from mucosa tissue |
| 03/04/1997 | US5607836 Methods of detecting compounds which bind to the P2U receptor |
| 03/04/1997 | US5607831 In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death |
| 03/04/1997 | US5607694 Forming sealant by mixing virus inactivated fibrinogen and thrombin, liposomes with entrapped medicaments deliverable in wound or opening, and calcium; thrombin promotes fibrin clot formation, liposomes release medicaments |
| 03/04/1997 | US5607679 Lectins for treatment of skin diseases |
| 03/04/1997 | US5607676 Immunogenic compositions against gastrin peptides |
| 03/04/1997 | US5607675 Treatment of autoimmune diseases with IL-2 receptor-specific cytotoxin |
| 03/04/1997 | US5607672 Replacement therapy for dental caries |
| 03/04/1997 | US5607671 Beta lactam antibiotics degrading compound |
| 03/04/1997 | CA2129824C Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 03/01/1997 | CA2184334A1 Anticoagulant factor va derivatives |
| 03/01/1997 | CA2184226A1 Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use |
| 02/27/1997 | WO1997007334A1 Axial flow valve system for linear compressor |
| 02/27/1997 | WO1997007233A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | WO1997007219A2 Genes and proteins controlling cholesterol synthesis |
| 02/27/1997 | WO1997007218A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | WO1997007215A1 Agonists of haemopoietic growth factors |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007213A2 Assay for identifying genes causing chromosome non-disjunction |
| 02/27/1997 | WO1997007212A1 Opioid antagonists and methods of their use |
| 02/27/1997 | WO1997007211A1 Materials and methods for detection and treatment of insulin-dependent diabetes |
| 02/27/1997 | WO1997007210A1 Recombinant conglutinin and process for producing the same |
| 02/27/1997 | WO1997007209A2 Receptor |
| 02/27/1997 | WO1997007208A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 02/27/1997 | WO1997007204A1 Antibody 105a5 to 'peanut agglutinin' (pna)-binding glycoprotein on cell surfaces |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007136A2 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 02/27/1997 | WO1997007135A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | WO1997007134A1 Traf inhibitors |
| 02/27/1997 | WO1997007133A1 Recombinant conglutinin and process for producing the same |
| 02/27/1997 | WO1997007131A1 Acylated oligopeptides containing phosphotyrosine as inhibitors of protein tyrosine kinases |
| 02/27/1997 | WO1997007130A1 Novel opioid peptides |
| 02/27/1997 | WO1997007129A1 Solution synthesis of peripheral acting analgesic opioid tetrapeptides |
| 02/27/1997 | WO1997007127A1 Dna encoding suppressin protein and uses thereof |
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006827A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | WO1997006822A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006820A1 Antiviral compositions and methods |
| 02/27/1997 | WO1997006819A1 Compositions and methods for elmination of advanced glycosylation endproducts (in vivo) |
| 02/27/1997 | WO1997006818A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | WO1997006817A1 Haematopoietic recovery |
| 02/27/1997 | WO1997006816A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/27/1997 | WO1997006815A2 Aqueous rinsing solution for endoscopic operations |
| 02/27/1997 | WO1997006814A1 Method of promoting angiogenesis |
| 02/27/1997 | WO1997006813A1 Mucosal preparation containing physiologically active peptide |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006662A2 Inverted chimeric and hybrid oligonucleotides |
| 02/27/1997 | WO1997004115A3 Method for producing haemin proteins using plant cells, resulting proteins and products containing same |
| 02/27/1997 | WO1997004005A3 Cyclosporin derivatives with anti-hiv effect |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | WO1997001331A3 Method of producing sustained-release preparation |
| 02/27/1997 | DE19531348A1 Antikörper mit zwei oder mehr Spezifitäten zur selektiven Eliminierung von Zellen in vivo Antibodies having two or more specificities for the selective elimination of cells in vivo |
| 02/27/1997 | DE19531346A1 Arzneimittel zur Immuntherapie, enthaltend Antikörper, die spezifisch das MHCII-Antigen eines zu behandelnden Patienten erkennen Drugs for immunotherapy, containing antibodies which specifically recognize the MHCII-antigen of a patient to be treated |
| 02/27/1997 | DE19531342A1 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 02/27/1997 | DE19531033A1 Antikörper gegen an Oberflächen von Carcinom-Zellen außerhalb von Desmosomen exponierte Epitope desmosomaler Cadherine Antibodies against at surfaces of carcinoma cells outside exposed epitopes of desmosomal cadherins of desmosomes |
| 02/27/1997 | DE19530865A1 Wirkstoff sowie Mittel zur parenteralen Ernährung Drug and means for parenteral nutrition |
| 02/27/1997 | CA2614655A1 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 02/27/1997 | CA2229797A1 Novel opioid peptides |
| 02/27/1997 | CA2229605A1 Genes and proteins controlling cholesterol synthesis |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229557A1 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229450A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/27/1997 | CA2229287A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229140A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 02/27/1997 | CA2229126A1 Opioid antagonists and methods of their use |
| 02/27/1997 | CA2228965A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | CA2228765A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | CA2227795A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | CA2227174A1 Traf inhibitors |
| 02/26/1997 | EP0759469A1 Bacteriocin |
| 02/26/1997 | EP0759468A1 Feline interleukin-4 |
| 02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
| 02/26/1997 | EP0759442A1 Tumor immunotherapy using anti-idiotypic antibodies |
| 02/26/1997 | EP0759441A2 Methods of treating neuropeptide Y-associated conditions |
| 02/26/1997 | EP0759302A1 Remedy for rheumatoid arthritis |
| 02/26/1997 | EP0759292A1 Use of alpha type melanocytes stimulating hormone derivatives to stimulate the hairgrowth |